Correlation Between OmniAb and Cardio Diagnostics
Can any of the company-specific risk be diversified away by investing in both OmniAb and Cardio Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OmniAb and Cardio Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OmniAb Inc and Cardio Diagnostics Holdings, you can compare the effects of market volatilities on OmniAb and Cardio Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OmniAb with a short position of Cardio Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of OmniAb and Cardio Diagnostics.
Diversification Opportunities for OmniAb and Cardio Diagnostics
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between OmniAb and Cardio is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding OmniAb Inc and Cardio Diagnostics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardio Diagnostics and OmniAb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OmniAb Inc are associated (or correlated) with Cardio Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardio Diagnostics has no effect on the direction of OmniAb i.e., OmniAb and Cardio Diagnostics go up and down completely randomly.
Pair Corralation between OmniAb and Cardio Diagnostics
Assuming the 90 days horizon OmniAb is expected to generate 19.44 times less return on investment than Cardio Diagnostics. But when comparing it to its historical volatility, OmniAb Inc is 2.9 times less risky than Cardio Diagnostics. It trades about 0.04 of its potential returns per unit of risk. Cardio Diagnostics Holdings is currently generating about 0.3 of returns per unit of risk over similar time horizon. If you would invest 3.67 in Cardio Diagnostics Holdings on September 13, 2024 and sell it today you would earn a total of 7.15 from holding Cardio Diagnostics Holdings or generate 194.82% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 80.95% |
Values | Daily Returns |
OmniAb Inc vs. Cardio Diagnostics Holdings
Performance |
Timeline |
OmniAb Inc |
Cardio Diagnostics |
OmniAb and Cardio Diagnostics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with OmniAb and Cardio Diagnostics
The main advantage of trading using opposite OmniAb and Cardio Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OmniAb position performs unexpectedly, Cardio Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will offset losses from the drop in Cardio Diagnostics' long position.The idea behind OmniAb Inc and Cardio Diagnostics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Cardio Diagnostics vs. Puma Biotechnology | Cardio Diagnostics vs. Iovance Biotherapeutics | Cardio Diagnostics vs. Sarepta Therapeutics | Cardio Diagnostics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |